매독 면역측정 진단 시장 : 검사 유형별, 검체 유형별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

REPORT HIGHLIGHT

The Syphilis Immunoassay Diagnostic Market size was valued at USD 29,109.32 million in 2023, expanding at a CAGR of 7.60% from 2024 to 2032.

The Syphilis Immunoassay Diagnostic Market encompasses various testing methods used to detect syphilis infections, which remain a significant public health concern globally. With rising rates of syphilis, particularly among certain demographics, the demand for accurate and rapid diagnostic tests has surged. Increased awareness and education regarding sexually transmitted infections (STIs) have contributed to higher testing rates. Moreover, government initiatives aimed at reducing STI prevalence have bolstered market growth. However, challenges such as the availability of alternative testing methods and the stigma surrounding STIs may restrain market expansion. Opportunities lie in the development of novel immunoassay technologies and point-of-care testing solutions, which can enhance accessibility and facilitate timely treatment. For instance, the CDC reported a 20% increase in reported syphilis cases in recent years, highlighting the urgent need for improved diagnostic tools and public health interventions.

Syphilis Immunoassay Diagnostic Market- Market Dynamics

Surge in Demand for Accurate and Rapid Diagnostic Tests Propels Growth in the Syphilis Immunoassay Diagnostic Market

The growing urgency for accurate and rapid diagnostic tests for syphilis has significantly influenced the market for immunoassay diagnostics. The World Health Organization reported that global syphilis rates have risen, particularly among high-risk populations, underscoring the need for effective screening. Innovative testing methods, such as point-of-care tests, provide results in under 30 minutes, enhancing patient management and treatment outcomes. In the U.S., the Centers for Disease Control and Prevention highlighted that syphilis cases increased by nearly 75% from 2014 to 2018, prompting healthcare providers to prioritize swift testing solutions. The rise in sexually transmitted infections overall has further driven the demand for reliable diagnostic tests, leading to increased investments in research and development by major healthcare companies. This trend emphasizes the critical role of rapid diagnostic capabilities in controlling the spread of syphilis and improving public health responses.

Syphilis Immunoassay Diagnostic Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.60% over the forecast period (2024-2032)

Based on Test Type segmentation, Point-of-care (POC) Tests were predicted to show maximum market share in the year 2023

Based on Sample Type segmentation, Blood was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Syphilis Immunoassay Diagnostic Market- Segmentation Analysis:

The Global Syphilis Immunoassay Diagnostic Market is segmented on the basis of Test Type, Sample Type, End-User, and Region.

The market is divided into four categories based on Test Type: Treponemal Tests, Non-Treponemal Tests, Point-of-Care (POC) Tests, and Automated Immunoassays. Point-of-care (POC) Tests are predicted to dominate due to their rapid results and ease of use. Following closely are Treponemal Tests, Non-Treponemal Tests, and Automated Immunoassays, each offering unique benefits in diagnostics.

The market is divided into three categories based on Sample Type: Blood, Serum, and Plasma. Blood samples are expected to lead due to their widespread availability and ease of collection. Following are Serum samples, favored for their stability in testing, and Plasma samples, which are also commonly utilized in diagnostics.

Syphilis Immunoassay Diagnostic Market- Geographical Insights

The Syphilis Immunoassay Diagnostic Market exhibits significant geographical variation, with North America leading due to its advanced healthcare infrastructure and high prevalence of sexually transmitted infections. The Centers for Disease Control and Prevention noted a surge in syphilis cases, prompting initiatives to enhance screening and testing capabilities. In Europe, countries like the UK and Germany are investing in innovative diagnostic technologies, with the European Centre for Disease Prevention and Control emphasizing the importance of early detection and treatment. Asia-Pacific is witnessing rapid growth, driven by increasing awareness and healthcare improvements; for instance, India has implemented national programs to address syphilis screening among high-risk populations. Latin America is also making strides, with Brazil reporting efforts to integrate rapid diagnostic tests into public health strategies. Meanwhile, the Middle East and Africa face unique challenges, including resource constraints, but are beginning to adopt more effective testing methods, spurred by international health organizations aiming to reduce the burden of sexually transmitted infections.

Syphilis Immunoassay Diagnostic Market- Competitive Landscape:

The competitive landscape of the Syphilis Immunoassay Diagnostic Market showcases significant activity across various regions. North America leads with key players like Abbott Laboratories and Roche, which are investing in advanced immunoassay technologies to enhance accuracy and speed in syphilis testing. The American Sexual Health Association has reported that rapid testing methods are crucial in controlling syphilis outbreaks. In Europe, companies such as Siemens Healthineers and BioMerieux are driving innovation, supported by the European Union's initiatives to improve STI testing and treatment protocols. In the Asia-Pacific region, firms like Fujirebio and Tecan are expanding their market presence, with Japan and Australia emphasizing comprehensive screening programs. Latin America is also becoming a competitive arena, where local companies are partnering with international firms to improve access to diagnostic tests, reflecting the World Health Organization's focus on reducing syphilis prevalence. In the Middle East and Africa, the market is evolving with the introduction of affordable testing kits, supported by initiatives from non-governmental organizations to bolster sexual health awareness.

Recent Developments:

In August 2024, NowDiagnostics' First to Know(R) syphilis test received FDA de novo marketing authorization for over-the-counter use. This immunoassay diagnostic allows individuals to test for syphilis at home, enhancing accessibility and early detection of the infection.

In November 2021, MedAccess, CHAI, and SD Biosensor announced a partnership to provide a dual rapid test for syphilis and HIV for under $1 in over 100 low- and middle-income countries. This test enables quick diagnosis, improving maternal health and reducing stillbirths linked to syphilis.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

• Abbott Laboratories
• Beckman Coulter, Inc.
• Becton, Dickinson, and Company
• bioMerieux S.A.
• Bio-Rad Laboratories, Inc.
• Cardinal Health, Inc.
• Cepheid Inc. (Danaher)
• Chembio Diagnostics, Inc.
• DiaSorin S.p.A.
• F. Hoffmann-La Roche AG
• Hologic, Inc.
• OraSure Technologies, Inc.
• Qiagen N.V.
• Siemens Healthineers AG
• Thermo Fisher Scientific Inc.
• Trinity Biotech plc
• Others

GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

• Treponemal Tests
• Non-Treponemal Tests
• Point-of-Care (POC) Tests
• Automated Immunoassays

GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET, BY SAMPLE TYPE- MARKET ANALYSIS, 2019 - 2032

• Blood
• Serum
• Plasma

GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

• Hospitals
• Diagnostic Laboratories
• Blood Banks
• Community Clinics

GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Syphilis Immunoassay Diagnostic Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Syphilis Immunoassay Diagnostic Market Snippet by Test Type
  • 2.1.2. Syphilis Immunoassay Diagnostic Market Snippet by Sample Type
  • 2.1.3. Syphilis Immunoassay Diagnostic Market Snippet by End-User
  • 2.1.4. Syphilis Immunoassay Diagnostic Market Snippet by Country
  • 2.1.5. Syphilis Immunoassay Diagnostic Market Snippet by Region
• 2.2. Competitive Insights

3. Syphilis Immunoassay Diagnostic Key Market Trends

• 3.1. Syphilis Immunoassay Diagnostic Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Syphilis Immunoassay Diagnostic Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Syphilis Immunoassay Diagnostic Market Opportunities
• 3.4. Syphilis Immunoassay Diagnostic Market Future Trends

4. Syphilis Immunoassay Diagnostic Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Syphilis Immunoassay Diagnostic Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. Syphilis Immunoassay Diagnostic Market Landscape

• 6.1. Syphilis Immunoassay Diagnostic Market Share Analysis, 2023
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Syphilis Immunoassay Diagnostic Market - By Test Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Test Type, 2023 & 2032 (%)
  • 7.1.2. Treponemal Tests
  • 7.1.3. Non-Treponemal Tests
  • 7.1.4. Point-of-Care (POC) Tests
  • 7.1.5. Automated Immunoassays

8. Syphilis Immunoassay Diagnostic Market - By Sample Type

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Sample Type, 2023 & 2032 (%)
  • 8.1.2. Blood
  • 8.1.3. Serum
  • 8.1.4. Plasma

9. Syphilis Immunoassay Diagnostic Market - By End-User

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
  • 9.1.2. Hospitals
  • 9.1.3. Diagnostic Laboratories
  • 9.1.4. Blood Banks
  • 9.1.5. Community Clinics

10. Syphilis Immunoassay Diagnostic Market- By Geography

• 10.1. Introduction
  • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
• 10.2. North America
  • 10.2.1. Overview
  • 10.2.2. Syphilis Immunoassay Diagnostic Key Manufacturers in North America
  • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  • 10.2.5. North America Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.2.7. U.S.
    • 10.2.7.1. Overview
    • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.7.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.2.7.4. U.S. Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.2.8. Canada
    • 10.2.8.1. Overview
    • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.8.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.2.8.4. Canada Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
• 10.3. Europe
  • 10.3.1. Overview
  • 10.3.2. Syphilis Immunoassay Diagnostic Key Manufacturers in Europe
  • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  • 10.3.5. Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.7. Germany
    • 10.3.7.1. Overview
    • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.7.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.3.7.4. Germany Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.8. Italy
    • 10.3.8.1. Overview
    • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.8.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.3.8.4. Italy Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.9. United Kingdom
    • 10.3.9.1. Overview
    • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.9.3. United Kingdom Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.3.9.4. United Kingdom Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.10. France
    • 10.3.10.1. Overview
    • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.10.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.3.10.4. France Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.11. Russia
    • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.11.2. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.3.11.3. Russia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.12. Netherlands
    • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.12.2. Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.3.12.3. Netherlands Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.13. Sweden
    • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.13.2. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.3.13.3. Sweden Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.14. Poland
    • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.14.2. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.3.14.3. Poland Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.15. Rest of Europe
    • 10.3.15.1. Overview
    • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
• 10.4. Asia Pacific (APAC)
  • 10.4.1. Overview
  • 10.4.2. Syphilis Immunoassay Diagnostic Key Manufacturers in Asia Pacific
  • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.4.4. Asia Pacific Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  • 10.4.5. Asia Pacific Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.7. India
    • 10.4.7.1. Overview
    • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.7.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.4.7.4. India Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.8. China
    • 10.4.8.1. Overview
    • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.8.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.4.8.4. China Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.9. Japan
    • 10.4.9.1. Overview
    • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.9.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.4.9.4. Japan Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.10. South Korea
    • 10.4.10.1. Overview
    • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.10.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.4.10.4. South Korea Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.11. Australia
    • 10.4.11.1. Overview
    • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.11.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.4.11.4. Australia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.12. Thailand
    • 10.4.12.1. Overview
    • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.12.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.4.12.4. Thailand Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.13. Indonesia
    • 10.4.13.1. Overview
    • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.13.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.4.13.4. Indonesia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.14. Philippines
    • 10.4.14.1. Overview
    • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.14.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.4.14.4. Philippines Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.15. Rest of APAC
    • 10.4.15.1. Overview
    • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.15.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.4.15.4. Rest of APAC Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
• 10.5. Latin America
  • 10.5.1. Overview
  • 10.5.2. Syphilis Immunoassay Diagnostic Key Manufacturers in Latin America
  • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.5.4. Latin America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  • 10.5.5. Latin America Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  • 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5.7. Brazil
    • 10.5.7.1. Overview
    • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.7.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.5.7.4. Brazil Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5.8. Mexico
    • 10.5.8.1. Overview
    • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.8.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.5.8.4. Mexico Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5.9. Argentina
    • 10.5.9.1. Overview
    • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.9.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.5.9.4. Argentina Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5.10. Colombia
    • 10.5.10.1. Overview
    • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.10.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.5.10.4. Colombia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5.11. Rest of LATAM
    • 10.5.11.1. Overview
    • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
• 10.6. Middle East and Africa
  • 10.6.1. Overview
  • 10.6.2. Syphilis Immunoassay Diagnostic Key Manufacturers in Middle East and Africa
  • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.6.4. Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  • 10.6.5. Middle East and Africa Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6.7. Saudi Arabia
    • 10.6.7.1. Overview
    • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6.8. United Arab Emirates
    • 10.6.8.1. Overview
    • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6.9. Israel
    • 10.6.9.1. Overview
    • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.9.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.6.9.4. Israel Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6.10. Turkey
    • 10.6.10.1. Overview
    • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.10.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.6.10.4. Turkey Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6.11. Algeria
    • 10.6.11.1. Overview
    • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.11.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.6.11.4. Algeria Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6.12. Egypt
    • 10.6.12.1. Overview
    • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.12.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.6.12.4. Egypt Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6.13. Rest of MEA
    • 10.6.13.1. Overview
    • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.13.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.6.13.4. Rest of MEA Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Syphilis Immunoassay Diagnostic Industry

• 11.1. Competitive Dashboard
• 11.2. Company Profiles
  • 11.2.1. Abbott Laboratories
  • 11.2.2. Beckman Coulter, Inc.
  • 11.2.3. Becton, Dickinson and Company
  • 11.2.4. bioMerieux S.A.
  • 11.2.5. Bio-Rad Laboratories, Inc.
  • 11.2.6. Cardinal Health, Inc.
  • 11.2.7. Cepheid Inc. (Danaher)
  • 11.2.8. Chembio Diagnostics, Inc.
  • 11.2.9. DiaSorin S.p.A.
  • 11.2.10. F. Hoffmann-La Roche AG
  • 11.2.11. Hologic, Inc.
  • 11.2.12. OraSure Technologies, Inc.
  • 11.2.13. Qiagen N.V.
  • 11.2.14. Siemens Healthineers AG
  • 11.2.15. Thermo Fisher Scientific Inc.
  • 11.2.16. Trinity Biotech plc
  • 11.2.17. Others

12. 360 Degree Analyst View

13. Appendix

• 13.1. Research Methodology
• 13.2. References
• 13.3. Abbreviations
• 13.4. Disclaimer
• 13.5. Contact Us